These data suggest that CXCR4 - specific ZFNs may prove useful in establishing resistance to CXCR4 - tropic HIV for
autologous transplant in HIV - infected individuals.
Not exact matches
This may entail making small holes
in the bone to allow new cartilage to grow (microfracture), taking cartilage from another part of the athlete's knee and
transplanting it into the defect (osteochondral autograft transfer), taking cartilage cells from the knee and then having them grown
in a lab for later re-implantation (
autologous chondrocyte implantation), or taking cartilage from a person who has passed away and placing it
in the defect (osteochondral allograft transfer).
The study, «Lenalidomide (LEN) maintenance (MNTC) after high - dose melphalan and
autologous stem cell
transplant (ASCT)
in multiple myeloma (MM): A meta - analysis (MA) of overall survival (OS),» is ASCO 2016 abstract no. 8001 and will be discussed during the Hematologic Malignancies — Plasma Cell Dyscrasia oral abstract session Friday, June 3.
Results from a clinical trial investigating a new T cell receptor (TCR) therapy that uses a person's own immune system to recognize and destroy cancer cells demonstrated a clinical response
in 80 percent of multiple myeloma patients with advanced disease after undergoing
autologous stem cell
transplants (ASCT).
Based on our data,
autologous stem cell
transplant should be considered the standard of care for patients with HIV - related lymphomas for the same indications and under the same circumstances that we would use it
in patients without HIV infection.»
In addition, transgenic autologous hematopoietic stem cells can be successfully transplanted in HIV - infected individuals [18] and several phase I adoptive transfer trials of CD4 + T cells treated with R5 - ZFNs in HIV infected individuals are currently underwa
In addition, transgenic
autologous hematopoietic stem cells can be successfully
transplanted in HIV - infected individuals [18] and several phase I adoptive transfer trials of CD4 + T cells treated with R5 - ZFNs in HIV infected individuals are currently underwa
in HIV - infected individuals [18] and several phase I adoptive transfer trials of CD4 + T cells treated with R5 - ZFNs
in HIV infected individuals are currently underwa
in HIV infected individuals are currently underway.
Tan J, Wu W, Xu X, Liao L, Zheng F, Messinger S, Sun X, Chen J, Yang S, Cai J, Gao X, Pileggi A, Ricordi C. Induction therapy with
autologous mesenchymal stem cells
in living - related kidney
transplants: a randomized controlled trial.
Dr. Goodman is also involved
in collaborative efforts with the San Antonio Bone Marrow
Transplant Center to study the outcome of allogeneic bone marrow
transplants following a relapse from
autologous bone marrow
transplants.
Board - certified
in internal medicine and medical oncology, Dr. Collins has 25 years of experience
in bone marrow transplantation and has participated
in some 2,500
autologous and allogeneic
transplants.
He has been performing safely and successfully
autologous peripheral stem cell
transplant procedures
in a totally outpatient basis since 1995.
In this study, Peterson and colleagues have tried to recapitulate aspects of Brown's treatment using gene editing and
autologous stem cell
transplant.
Patients receive one of two types of stem cell - based
transplants:
autologous,
in which a patient donates and receives back his / her own stem cells; or allogeneic,
in which bone marrow - derived stem cells come from a related or unrelated donor whose human leukocyte antigens (HLA) are genetically matched with those of a patient.
CRP Levels Before
Transplant Linked With Survival
in Multiple Myeloma: According to a new study, patients with an elevation
in C - reactive protein (CRP) prior to an
autologous stem cell transplantation (ASCT) for multiple myeloma experienced a worse overall survival (OS) rate.
This is the «show reel» of Dr Haluk Deda, a Turkish neurosurgeon who is setting up shop
in Dubai, where he plans to offer
autologous stem cell
transplants to treat chronic spinal cord injuries and ALS, a condition with no known cure that generally leads to death within three to five years of diagnosis.
The really important questions are whether this therapy can be given safely; early
in the disease course; and as second - line treatment, replacing an
autologous stem cell
transplant.